1. Home
  2. BIAF vs LUCY Comparison

BIAF vs LUCY Comparison

Compare BIAF & LUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • LUCY
  • Stock Information
  • Founded
  • BIAF 2014
  • LUCY 2017
  • Country
  • BIAF United States
  • LUCY United States
  • Employees
  • BIAF N/A
  • LUCY N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • LUCY Ophthalmic Goods
  • Sector
  • BIAF Health Care
  • LUCY Health Care
  • Exchange
  • BIAF Nasdaq
  • LUCY Nasdaq
  • Market Cap
  • BIAF 12.2M
  • LUCY 10.3M
  • IPO Year
  • BIAF 2022
  • LUCY 2022
  • Fundamental
  • Price
  • BIAF $0.20
  • LUCY $1.77
  • Analyst Decision
  • BIAF Hold
  • LUCY
  • Analyst Count
  • BIAF 1
  • LUCY 0
  • Target Price
  • BIAF N/A
  • LUCY N/A
  • AVG Volume (30 Days)
  • BIAF 670.4K
  • LUCY 1.0M
  • Earning Date
  • BIAF 05-14-2025
  • LUCY 05-20-2025
  • Dividend Yield
  • BIAF N/A
  • LUCY N/A
  • EPS Growth
  • BIAF N/A
  • LUCY N/A
  • EPS
  • BIAF N/A
  • LUCY N/A
  • Revenue
  • BIAF $9,362,022.00
  • LUCY $1,636,440.00
  • Revenue This Year
  • BIAF N/A
  • LUCY $542.00
  • Revenue Next Year
  • BIAF $19.99
  • LUCY $148.54
  • P/E Ratio
  • BIAF N/A
  • LUCY N/A
  • Revenue Growth
  • BIAF 269.68
  • LUCY 41.99
  • 52 Week Low
  • BIAF $0.16
  • LUCY $1.57
  • 52 Week High
  • BIAF $2.99
  • LUCY $27.20
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 29.98
  • LUCY 41.79
  • Support Level
  • BIAF $0.16
  • LUCY $1.70
  • Resistance Level
  • BIAF $0.48
  • LUCY $1.85
  • Average True Range (ATR)
  • BIAF 0.05
  • LUCY 0.20
  • MACD
  • BIAF -0.03
  • LUCY 0.05
  • Stochastic Oscillator
  • BIAF 8.68
  • LUCY 20.11

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About LUCY Innovative Eyewear Inc.

Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products Lucyd Lyte glasses enable the wearer to listen to music, take and make calls, and use voice assistants to perform many common smartphone tasks hands free.

Share on Social Networks: